Peer-reviewed veterinary case report
ACVIM consensus statement guidelines for the diagnosis, classification, treatment, and monitoring of pulmonary hypertension in dogs.
- Journal:
- Journal of veterinary internal medicine
- Year:
- 2020
- Authors:
- Reinero, Carol et al.
- Affiliation:
- Department of Veterinary Medicine and Surgery
- Species:
- dog
Plain-English summary
Pulmonary hypertension (PH) in dogs is a condition where there is increased pressure in the blood vessels of the lungs, which can happen due to various heart, lung, or other health issues. This guideline aims to help veterinarians diagnose and treat PH by looking at the dog's age, breed, symptoms, and results from tests like echocardiograms. Dogs with PH can be grouped based on the cause, such as heart disease, lung disease, blood clots, or infections from parasites. Treatment focuses on slowing down the disease's progression and addressing any underlying problems. It's important for dogs with PH to be regularly checked to see if their condition is improving, staying the same, or getting worse, and to manage any related health issues at the same time.
Abstract
Pulmonary hypertension (PH), defined by increased pressure within the pulmonary vasculature, is a hemodynamic and pathophysiologic state present in a wide variety of cardiovascular, respiratory, and systemic diseases. The purpose of this consensus statement is to provide a multidisciplinary approach to guidelines for the diagnosis, classification, treatment, and monitoring of PH in dogs. Comprehensive evaluation including consideration of signalment, clinical signs, echocardiographic parameters, and results of other diagnostic tests supports the diagnosis of PH and allows identification of associated underlying conditions. Dogs with PH can be classified into the following 6 groups: group 1, pulmonary arterial hypertension; group 2, left heart disease; group 3, respiratory disease/hypoxia; group 4, pulmonary emboli/pulmonary thrombi/pulmonary thromboemboli; group 5, parasitic disease (Dirofilaria and Angiostrongylus); and group 6, disorders that are multifactorial or with unclear mechanisms. The approach to treatment of PH focuses on strategies to decrease the risk of progression, complications, or both, recommendations to target underlying diseases or factors contributing to PH, and PH-specific treatments. Dogs with PH should be monitored for improvement, static condition, or progression, and any identified underlying disorder should be addressed and monitored simultaneously.
Find similar cases for your pet
PetCaseFinder finds other peer-reviewed reports of pets with the same symptoms, plus a plain-English summary of what was tried across them.
Search related cases →Original publication: https://pubmed.ncbi.nlm.nih.gov/32065428/